Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate
Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(0.22) by 872.73 percent.
Yarrow Bioscience lost much more money per share than experts thought it would. When a company loses way more than expected, it might mean their business plan isn't working as well as people hoped.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.